Kolexia
Ascher Benjamin Chirurgie plastique
Ascher Benjamin
Chirurgie plastique
Clinique Sainte Genevieve
Paris, France
54 Activités
0 Followers
Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Lipodystrophie Faciès Toxines botuliniques de type A Placebo Agents neuromusculaires Toxines botuliniques Acides Acide hyaluronique Produits de comblement dermique

Collaborateurs

Voir plus
Kestemont Philippe
Kestemont Philippe
Clinique Saint George, Nice, France
Bodokh Isaac
Bodokh Isaac
Cabinet libéral, Cannes, France
Boineau Dominique
Boineau Dominique
Cabinet libéral, Bordeaux, France
Cartier Hugues
Cartier Hugues
Centre Hospitalier de Arras, Arras, France

Industries

Voir plus
Galderma
7 collaboration(s)
Dernière en 2022
Ipsen
4 collaboration(s)
Dernière en 2023
Menarini
2 collaboration(s)
Dernière en 2021
Merz
1 collaboration(s)
Dernière en 2021

Dernières activités

Voir plus
HAtrophy: A Prospective and Multicentric Investigation Evaluating the Clinical Safety of FASY F and FASY P Hyaluronic Acid Gel for the Treatment of Pathological Facial Lipoatrophy
Essai Clinique (Symatese)   05 décembre 2023
Skin & Digital - The 2023 conversation.
Journal of the European Academy of Dermatology and Venereology : JEADV   16 octobre 2023
Check out the report about... - Thinkin by Dr Benjamin Ascher - Facebook
Facebook   04 septembre 2023
International Consensus Recommendations on the Aesthetic Usage of Ready to Use Abobotulinumtoxina (Alluzience).
Aesthetic surgery journal   25 juillet 2023
PrabotulinumtoxinA for the treatment of glabellar lines in adults, 65 years of age and older: The fourth in a series of post hoc analyses of the phase III clinical study data.
Journal of cosmetic dermatology   27 avril 2023
The Effect of Hybrosome (Umbilical Cord Blood Exosome-Liposome Hybrid Vesicles) on Human Dermal Cells In Vitro.
Aesthetic surgery journal. Open forum   25 avril 2023
PrabotulinumtoxinA vs OnabotulinumtoxinA for the Treatment of Adult Males With Moderate to Severe Glabellar Lines: Post-hoc Analyses of the Phase III Clinical Study Data.
Aesthetic surgery journal   20 décembre 2022
Liquid AbobotulinumtoxinA: Pooled Data From Two Double-Blind, Randomized, Placebo-Controlled Phase III Studies of Glabellar Line Treatment.
Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.]   07 octobre 2022
Efficacy and Safety of Botulinum Toxin Type A Haemagglutinin Complex Next Generation (BTX-A-HAC NG) in Glabellar Lines: Phase III, Randomised, Double Blind, Placebo Controlled and Open Label Phase Multicentre Study to Investigate the Efficacy and Safety of BTX-A-HAC NG in the Treatment of Moderate to Severe Glabellar Lines, and Assess the Long Term Efficacy and Safety of BTX-A-HAC NG Following Repeated Treatments in This Indication
Essai Clinique (Ipsen)   15 septembre 2022
BTX-A-HAC NG: A Phase III, Double Blind, Randomised, Placebo Controlled Study To Assess The Efficacy And Safety Of A Single Treatment Of Clostridium Botulinum Toxin Type A To Improve The Appearance Of Moderate To Severe Glabellar Lines
Essai Clinique (Ipsen)   15 septembre 2022